A. Langer

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Medicine, Cardiology, Pharmacotherapy +17

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 125 citations · Full text

Medicine, Neurology, Cerebrovascular Surgery +11

The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients

Katarina D. Kovacevic, Stefan Greisenegger, A. Langer et al. · Scientific Reports · 2021 · 36 citations · Full text

Medicine, Hematology, Pharmacology +17

Oral signs of aging and their clinical significance.

A. Langer · PubMed · 1976 · 32 citations

Dentistry, Oral Medicine, Oral Pathology +15

Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in unstable angina patients.

A. Langer, Nishit Singh, Robert Tibshirani et al. · PubMed · 1995 · 20 citations

Medicine, Cardiology, Internal Medicine +17